Complete suite of IHC testing for key biomarkers in all solid tumors, including c-MET, now available in addition to Guardant360 Tissue multiomic profiling test PALO ALTO, Calif., May 21 ...

International Holding Company (IHC) has posted a 41.1 per cent year-on-year jump in revenue to Dhs27.2bn in Q1 2025, driven by strong performance across its core verticals. The group’s profit ...

International Holding Company (IHC) has reported significant growth in its full-year 2024 financial results, underscoring its ability to drive strong performance and strategic portfolio management.

Immunohistochemistry (IHC) is a special test used by pathologists to detect specific molecules on cells. It is widely used in clinical oncology for categorizing solid cancer tumors and blood cancers, ...

Abstract: Immunohistochemistry (IHC) examination is essential to determine the tumour subtypes, provide key prognostic factors, and develop personalized treatment plans for breast cancer. However, ...

Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...

This course will provide a basic training in IHC theory and practise. The course will teach you the knowledge and confidence to manipulate basic IHC techniques to fit applications within your ...

What Is the Immunohistochemistry Test? The immunohistochemistry (IHC) test can tell your cancer doctor (oncologist) whether you have certain types of breast cancer. Professionals in a lab check a ...

The global Immunohistochemistry market size was valued at USD 3.19 billion in 2023 and is poised to exceed USD 5.66 billion by 2033, expanding at a CAGR of 5.9% between 2024 and 2033. The global ...